These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Long-Term Effects of Neural Precursor Cell Transplantation on Secondary Injury Processes and Functional Recovery after Severe Cervical Contusion-Compression Spinal Cord Injury. Younsi A; Zheng G; Riemann L; Scherer M; Zhang H; Tail M; Hatami M; Skutella T; Unterberg A; Zweckberger K Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884911 [TBL] [Abstract][Full Text] [Related]
12. iPSC Transplantation increases regeneration and functional recovery after ischemic stroke in neonatal rats. Chau MJ; Deveau TC; Song M; Gu X; Chen D; Wei L Stem Cells; 2014 Dec; 32(12):3075-87. PubMed ID: 25132189 [TBL] [Abstract][Full Text] [Related]
13. iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury. Nagoshi N; Okano H Cell Mol Life Sci; 2018 Mar; 75(6):989-1000. PubMed ID: 28993834 [TBL] [Abstract][Full Text] [Related]
14. hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice. Kong D; Feng B; Amponsah AE; He J; Guo R; Liu B; Du X; Liu X; Zhang S; Lv F; Ma J; Cui H Stem Cell Res Ther; 2021 Mar; 12(1):172. PubMed ID: 33706803 [TBL] [Abstract][Full Text] [Related]
15. Applications of induced pluripotent stem cell technologies in spinal cord injury. Nagoshi N; Okano H J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003 [TBL] [Abstract][Full Text] [Related]
16. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury. Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733 [TBL] [Abstract][Full Text] [Related]
17. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of human spinal cord-derived neural precursor cells after transplantation to the injured spinal cord. Emgård M; Piao J; Aineskog H; Liu J; Calzarossa C; Odeberg J; Holmberg L; Samuelsson EB; Bezubik B; Vincent PH; Falci SP; Seiger Å; Åkesson E; Sundström E Exp Neurol; 2014 Mar; 253():138-45. PubMed ID: 24412492 [TBL] [Abstract][Full Text] [Related]
19. Self-assembling peptides optimize the post-traumatic milieu and synergistically enhance the effects of neural stem cell therapy after cervical spinal cord injury. Zweckberger K; Ahuja CS; Liu Y; Wang J; Fehlings MG Acta Biomater; 2016 Sep; 42():77-89. PubMed ID: 27296842 [TBL] [Abstract][Full Text] [Related]
20. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation. Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]